The number of oncology clinical trials has increased exponentially in recent years, putting ever more pressure on increasing clinical trial efficiency by reducing costs and timelines. Patient recruitment swallows 40% of trial costs, yet only 10–17% of studies enroll on time and approximately 11% of sites in any given study fail to enroll a single patient.
The excessive amount of time taken for patient recruitment, which can reach 60% of the total trial time, can be drastically reduced by identifying experienced investigators, ensuring access to specific patient pools and seeking sufficient infrastructure for optimal trial execution.
Join this webinar as Covance highlights proven solutions for overcoming the enormous challenge of study planning and patient recruitment. Also, learn more about how the Covance informatics platform solves patient recruitment challenges by using strategic, evidence-based methodologies. Xcellerate® Trial Design is the most extensive knowledgebase in the industry, making powerful use of a combination of LabCorp and Covance data on over 13 billion lab tests, 142 million de-identified patients from over 750K heathcare providers in Labcorp; 175,000 unique investigators and over 15,000 protocols in CLS. These approaches are proven to accelerate patient enrollment, reduce the proportion of non-recruiting sites leading to shorter timelines and reduced costs.
Pamela Atwell, Senior Director, Strategy and Planning, Oncology, Covance
Pamela Atwell provides leadership in the development and implementation of the Covance operational platform which involves collaborating with client services and operations, through the design of evidence-based study plans, study engineering and study governance. She offers more than 24 years of experience in oncology clinical research including managing global Phase II and III multi-center studies. Pamela has a bachelor’s degree from the University of Virginia.Message Presenter
Michelle Jones, Senior Director, Clinical Informatics, Clinical Business Informatics & Solutions, Covance
Michelle is the global leader for the Clinical Informatics group within Covance Development Services. She is responsible for the provision of recruitment timeline and endpoint forecasts for all Phase II and III clinical trials, data flow forecasts and reconciliation tools. Michelle as over 20 years of experience including a background in statistics.Message Presenter
Who Should Attend?
Senior level professionals involved in oncology clinical trials. Relevant job areas include:
- Information Management
- Information Technology
- Research & Development
- Strategy Planning
Covance is one of the world’s largest and most comprehensive drug development services companies, with annual revenues greater than $2 billion and more than 12,000 employees in more than 60 countries.